L-NMMA acetate
CAS No. 53308-83-1
L-NMMA acetate( Tilarginine acetate | Methylarginine acetate )
Catalog No. M26734 CAS No. 53308-83-1
L-NMMA acetate is an inhibitor of nitric oxide synthase of all NOS isoforms (i.e. NOS1, NOS2, and NOS3).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 104 | In Stock |
|
| 25MG | 174 | In Stock |
|
| 50MG | 253 | In Stock |
|
| 100MG | 369 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameL-NMMA acetate
-
NoteResearch use only, not for human use.
-
Brief DescriptionL-NMMA acetate is an inhibitor of nitric oxide synthase of all NOS isoforms (i.e. NOS1, NOS2, and NOS3).
-
DescriptionL-NMMA acetate is an inhibitor of nitric oxide synthase of all NOS isoforms (i.e. NOS1, NOS2, and NOS3). The Ki values are 0.18, 0.4, and 6 μM for nNOS, eNOS, and iNOS, respectively.(In Vitro):L-NMMA acetate inhibits vasodilator responses to the endothelium-dependent vasodilator ACh but not to the endothelium-independent NP. L-NMMA acetate does not affect isoprenaline-induced relaxation . The inhibitory effect of L-NMMA acetate is unchanged by previous incubation with D-arginine while it is prevented by L-arginine. L-NMMA acetate, starting from 100 μM, produces a concentration-dependent inhibition of the evoked relaxations (2Hz); maximal inhibition at 1 mM averaged about 35%. The Superfusion of L-NMMA acetate decreases arteriolar diameter and causes dose-dependent increases in arteriolar tone. The onset of action of L-NMMA acetate is nearly immediate. NE induced dose-related vasoconstriction that is significantly potentiated by L-NMMA acetate .
-
In VitroL-NMMA, starting from 100 μM, produces a concentration-dependent inhibition of the evoked relaxations (2Hz); maximal inhibition at 1 mM averaged about 35%. The inhibitory effect of L-NMMA is unchanged by previous incubation with D-arginine while it is prevented by L-arginine (L-Arg). L-NMMA does not affect isoprenaline-induced relaxation. Superfusion of L-NMMA reduces arteriolar diameter and causes dose-dependent increases in arteriolar tone. The onset of action of L-NMMA is nearly immediate. L-NMMA inhibits vasodilator responses to the endothelium-dependent vasodilator ACh but not to the endothelium-independent NP. NE induced dose-related vasoconstriction that is significantly potentiated by L-NMMA.
-
In Vivo——
-
SynonymsTilarginine acetate | Methylarginine acetate
-
PathwayImmunology/Inflammation
-
TargetNOS
-
RecptorBax| Caspase-3| IAP
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number53308-83-1
-
Formula Weight248.283
-
Molecular FormulaC9H20N4O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : ≥ 50 mg/mL (201.39 mM)*)
-
SMILESCC(O)=O.CNC(=N)NCCC[C@H](N)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
DETA NONOate
DETA NONOate?(NOC 18) is an exogenous nitric oxide (NO) donor with vasodilatory and antidepressant activity.DETA NONOate can be used to activate inward currents in neurons, which may accelerate the healing of MRSA-infected wounds.
-
TP508
TP508 is a 23 amino acid synthetic peptide representing residues 508-530 of human prothrombin which is identified as a potential receptor-binding domain based on competition for high-affinity thrombin binding to fibroblasts.TP508 (Chrysalin) is an investigational peptide drug that was developed for use in stimulating repair of dermal and musculoskeletal tissues.
-
FK-330 dihydrate
FK-330 dihydrate (FR-260330 dihydrate) is a novel and effective nitric oxide synthase inhibitor. It can prevent ischemia and reperfusion injury in rat liver transplantation.
Cart
sales@molnova.com